Pharma

Expert Raises Alarm: Purdue Pharma Case May Reshape Future Mass Tort Litigations

by

Stamford, Connecticut – The recent resolution of the Purdue Pharma bankruptcy case has sparked a vigorous debate about the implications of mass tort cases involving major corporations. The settlement, which absolves the Sackler family from future opioid-related lawsuits while they remain major stakeholders in the restructured company, underscored contentious issues regarding accountability and compensation in similar legal battles across the United States. Critics argue that the outcome sets a precedent that may allow wealthy individuals and entities to circumvent full accountability by using bankruptcy courts to shield their assets. Legal experts have raised concerns about … Read more

Supreme Court Delivers Landmark Ruling in Purdue Pharma Bankruptcy, Shaping Future of Mass Tort Cases

by

WASHINGTON — A recent Supreme Court decision has resoundingly reshaped the landscape of bankruptcy law, particularly in how it pertains to mass tort litigations, exemplified by the high-profile Purdue Pharma bankruptcy case. At the heart of this judicial review was a debated proposal to exempt the Sackler family — owners of Purdue Pharma and makers of OxyContin — from future civil lawsuits while committing them to pay $6 billion into a settlement fund for victims of the opioid crisis. Purdue Pharma entered into bankruptcy in 2019 after facing a slew of lawsuits that attributed much … Read more

Supreme Court Overturns Sackler Family’s Liability Protection in Purdue Pharma Bankruptcy Case

by

Washington, D.C. – In a landmark ruling, the U.S. Supreme Court has rejected a crucial element of Purdue Pharma LP’s Chapter 11 reorganization plan. The court’s decision specifically overturns a liability shield that would have protected the Sackler family, owners of Purdue, from future opioid-related lawsuits, dramatically reshaping the legal landscape for bankruptcy resolutions in mass tort cases. The justices ruled that granting such a shield exceeds the permissible bounds of bankruptcy law, fundamentally changing how companies can settle widespread liability through reorganization. Legal experts suggest that this decision sets a significant precedent for how … Read more

Litigation Lawyer Justin VandenBout Joins Norton Rose Fulbright’s Houston Team, Enhancing their Products, Pharma, Medical, and Mass Tort Practice

by

HOUSTON, TX – Norton Rose Fulbright, a global law firm, has recently added litigator Justin VandenBout as a partner to their Products, Pharma, Medical, and Mass Tort practice team. VandenBout, who previously worked at Chamberlain Hrdlicka, brings with him a diverse range of litigation experience, specializing in commercial litigation, product liability, insurance coverage, and mass tort cases. He has represented clients on both sides of legal disputes in federal and state courts throughout the United States, demonstrating his ability to handle a wide array of cases. VandenBout’s expertise and dedication to his clients have earned … Read more